Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$80.37
$82.48
$39.40
$89.76
$3.58B1.55626,604 shsN/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
$55.86
-2.6%
$59.33
$54.48
$94.93
$7.77B1.191.16 million shs1.74 million shs
Penumbra, Inc. stock logo
PEN
Penumbra
$236.44
-1.2%
$261.88
$148.00
$310.00
$9.27B0.47453,323 shs552,885 shs
Solventum Corporation stock logo
SOLV
Solventum
$73.69
-0.5%
$73.84
$47.16
$85.92
$12.82B0.551.10 million shs768,477 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cantel Medical Corp. stock logo
CMD
Cantel Medical
0.00%0.00%0.00%0.00%0.00%
Globus Medical, Inc. stock logo
GMED
Globus Medical
-2.70%-1.27%-5.08%-21.49%-22.46%
Penumbra, Inc. stock logo
PEN
Penumbra
-1.00%-4.53%-7.75%-15.03%+23.35%
Solventum Corporation stock logo
SOLV
Solventum
-0.53%-1.82%+0.10%+12.16%+52.81%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cantel Medical Corp. stock logo
CMD
Cantel Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
4.9609 of 5 stars
4.35.00.04.13.32.51.9
Penumbra, Inc. stock logo
PEN
Penumbra
4.7342 of 5 stars
4.42.00.03.72.02.51.9
Solventum Corporation stock logo
SOLV
Solventum
0.727 of 5 stars
2.12.00.00.02.70.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cantel Medical Corp. stock logo
CMD
Cantel Medical
0.00
N/AN/AN/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.62
Moderate Buy$91.0963.07% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.88
Moderate Buy$305.0729.02% Upside
Solventum Corporation stock logo
SOLV
Solventum
2.27
Hold$84.3814.51% Upside

Current Analyst Ratings Breakdown

Latest CMD, SOLV, PEN, and GMED Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/15/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$75.00 ➝ $68.00
7/15/2025
Solventum Corporation stock logo
SOLV
Solventum
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$80.00 ➝ $103.00
7/9/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$320.00 ➝ $285.00
7/1/2025
Solventum Corporation stock logo
SOLV
Solventum
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$90.00
6/10/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
6/6/2025
Solventum Corporation stock logo
SOLV
Solventum
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Weight
5/27/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
5/27/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral
5/19/2025
Solventum Corporation stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$78.00 ➝ $87.00
5/12/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$80.00 ➝ $68.00
5/9/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$100.00 ➝ $80.00
(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$1.02B3.52$3.38 per share23.78$17.31 per share4.64
Globus Medical, Inc. stock logo
GMED
Globus Medical
$2.52B3.00$6.48 per share8.62$30.40 per share1.84
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B7.67$2.85 per share82.91$29.99 per share7.88
Solventum Corporation stock logo
SOLV
Solventum
$8.25B1.54$9.89 per share7.45$17.13 per share4.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$13.71M$1.6569.2828.911.634.72%12.13%4.45%N/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
$102.98M$1.3441.6913.861.677.39%10.52%8.56%8/5/2025 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$1.06223.0647.192.133.41%11.14%8.40%7/29/2025 (Estimated)
Solventum Corporation stock logo
SOLV
Solventum
$478M$2.1634.1113.421.904.55%31.01%6.53%8/4/2025 (Estimated)

Latest CMD, SOLV, PEN, and GMED Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.79N/AN/AN/A$738.91 millionN/A
7/29/2025Q2 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.81N/AN/AN/A$327.37 millionN/A
5/8/2025Q1 2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.74$0.68-$0.06$0.54$629.74 million$598.12 million
5/8/2025Q1 2025
Solventum Corporation stock logo
SOLV
Solventum
$1.19$1.34+$0.15$0.78$2.02 billion$2.07 billion
4/23/2025Q1 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.66$0.83+$0.17$1.00$315.72 million$324.14 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$0.210.26%N/A12.73%N/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
Solventum Corporation stock logo
SOLV
Solventum
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cantel Medical Corp. stock logo
CMD
Cantel Medical
1.16
2.72
2.00
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
4.45
2.72
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.30
3.68
Solventum Corporation stock logo
SOLV
Solventum
2.40
1.19
0.85

Institutional Ownership

CompanyInstitutional Ownership
Cantel Medical Corp. stock logo
CMD
Cantel Medical
84.13%
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
Solventum Corporation stock logo
SOLV
Solventum
N/A

Insider Ownership

CompanyInsider Ownership
Cantel Medical Corp. stock logo
CMD
Cantel Medical
10.70%
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.54%
Penumbra, Inc. stock logo
PEN
Penumbra
5.00%
Solventum Corporation stock logo
SOLV
Solventum
0.05%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cantel Medical Corp. stock logo
CMD
Cantel Medical
3,66944.51 millionN/AOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
5,300135.38 million110.28 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50038.73 million36.79 millionOptionable
Solventum Corporation stock logo
SOLV
Solventum
22,000173.01 million172.93 millionOptionable

Recent News About These Companies

Morgan Stanley Upgrades Solventum (SOLV)
Solventum (NYSE:SOLV) Raised to "Buy" at Argus

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cantel Medical stock logo

Cantel Medical NYSE:CMD

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

Globus Medical stock logo

Globus Medical NYSE:GMED

$55.86 -1.51 (-2.63%)
Closing price 07/15/2025 03:59 PM Eastern
Extended Trading
$55.78 -0.08 (-0.15%)
As of 07/15/2025 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Penumbra stock logo

Penumbra NYSE:PEN

$236.44 -2.88 (-1.20%)
Closing price 07/15/2025 03:59 PM Eastern
Extended Trading
$236.12 -0.32 (-0.14%)
As of 07:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Solventum stock logo

Solventum NYSE:SOLV

$73.69 -0.38 (-0.52%)
Closing price 07/15/2025 03:59 PM Eastern
Extended Trading
$73.60 -0.09 (-0.12%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.